Author:
Riccardi Niccolò, ,Alagna Riccardo,Saderi Laura,Ferrarese Maurizio,Castellotti Paola,Mazzola Ester,De Lorenzo Saverio,Viggiani Pietro,Udwadia Zarir,Besozzi Giorgio,Cirillo Daniela,Sotgiu Giovanni,Codecasa Luigi
Publisher
Springer Science and Business Media LLC
Reference32 articles.
1. Global tuberculosis report 2017 Geneva: World Health Organization; 2017, Licence: CC BY-NC- SA 3.0 IGO.
2. Falzon D, Gandhi N, Migliori GB, et al. Resistance to fluoroquinolones and second-line injectable drugs: impact on multidrug-resistant TB outcomes. Eur Respir J. 2013;42:156–68.
3. World Health Organization. Definitions and reporting framework for tuberculosis. In: Who/HTM/TB/2013, vol. 2. Geneva: WHO; 2013.
4. Lange C, Abubakar I, J-WC A, et al. Management of patients with multidrug-resistant/extensively drug-resistant tuberculosis in Europe: a TBNET consensus statement. Eur Respir J. 2014;44:23–63.
5. Guglielmetti L, Veziris N, Aubry A, Brossier F, Bernard C, Sougakoff W, Jarlier V, Robert J. Risk factors for extensive drug resistance in multidrug-resistant tuberculosis cases: a case-case study. Int J Tuberc Lung Dis. 2018;22(1):54–9.
Cited by
19 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献